PEAK6 Investments’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-607
Closed -$334K 6126
2022
Q1
$334K Buy
+607
New +$367K ﹤0.01% 3479
2021
Q4
Sell
-242
Closed -$185K 5156
2021
Q3
$203K Sell
242
-447
-65% -$453K ﹤0.01% 3974
2021
Q2
$874K Buy
+689
New +$778K ﹤0.01% 2709

Other funds holding CDLX

PEAK6 Investments's CDLX Position: Q2 2022 in Review

PEAK6 Investments sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 607 shares — an estimated $334K sold.

PEAK6 Investments first reported a position in CDLX in Q2 2021 and held it in 3 quarters. The position peaked at $874K in Q2 2021. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • PEAK6 Investments reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • PEAK6 Investments sold 607 Cardlytics shares in Q2 2022, an estimated $334K.
  • PEAK6 Investments first reported a position in Cardlytics in Q2 2021 and held it in 3 quarters.
  • PEAK6 Investments's Cardlytics position peaked at $874K in Q2 2021.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on PEAK6 Investments's 13F filing for Q2 2022, filed 12 Aug 2022.